These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 31740267)

  • 21. Impact of patent ductus arteriosus shunt size and duration on risk of death or severe respiratory morbidity in preterm infants born in China.
    Deng Y; Zhang H; Zhao Z; Du J; Bai R; McNamara PJ
    Eur J Pediatr; 2022 Aug; 181(8):3131-3140. PubMed ID: 35838780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patent ductus arteriosus in preterm infants.
    Sasi A; Deorari A
    Indian Pediatr; 2011 Apr; 48(4):301-8. PubMed ID: 21532100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of indomethacin prophylaxis timing on intraventricular haemorrhage and patent ductus arteriosus in extremely low birth weight infants.
    Mirza H; Laptook AR; Oh W; Vohr BR; Stoll BJ; Kandefer S; Stonestreet BS;
    Arch Dis Child Fetal Neonatal Ed; 2016 Sep; 101(5):F418-22. PubMed ID: 26733540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of outcome in 298 extremely low-birth-weight infants with patent ductus arteriosus.
    Alexander F; Chiu L; Kroh M; Hammel J; Moore J
    J Pediatr Surg; 2009 Jan; 44(1):112-7; disscusion 117. PubMed ID: 19159727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Shah SS; Ohlsson A
    Cochrane Database Syst Rev; 2003; (2):CD004213. PubMed ID: 12804505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Shah SS; Ohlsson A
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004213. PubMed ID: 16437478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal Intensive Care Unit-Level Patent Ductus Arteriosus Treatment Rates and Outcomes in Infants Born Extremely Preterm.
    Isayama T; Kusuda S; Reichman B; Lee SK; Lehtonen L; Norman M; Adams M; Bassler D; Helenius K; Hakansson S; Yang J; Jain A; Shah PS;
    J Pediatr; 2020 May; 220():34-39.e5. PubMed ID: 32145968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural evolution of ductus arteriosus with noninterventional conservative management in extremely preterm infants born at 23-28 weeks of gestation.
    Sung SI; Chang YS; Kim J; Choi JH; Ahn SY; Park WS
    PLoS One; 2019; 14(2):e0212256. PubMed ID: 30759169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural evolution of patent ductus arteriosus in the extremely preterm infant.
    Rolland A; Shankar-Aguilera S; Diomandé D; Zupan-Simunek V; Boileau P
    Arch Dis Child Fetal Neonatal Ed; 2015 Jan; 100(1):F55-8. PubMed ID: 25169243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of hemodynamically significant patent ductus arteriosus on acute kidney injury and systemic hypertension in extremely low gestational age newborns.
    Velazquez DM; Reidy KJ; Sharma M; Kim M; Vega M; Havranek T
    J Matern Fetal Neonatal Med; 2019 Oct; 32(19):3209-3214. PubMed ID: 29642731
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes.
    Laughon M; Bose C; Clark R
    J Perinatol; 2007 Mar; 27(3):164-70. PubMed ID: 17251985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus.
    Fujii AM; Brown E; Mirochnick M; O'Brien S; Kaufman G
    J Perinatol; 2002; 22(7):535-40. PubMed ID: 12368968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetaminophen to avoid surgical ligation in extremely low gestational age neonates with persistent hemodynamically significant patent ductus arteriosus.
    Weisz DE; Martins FF; Nield LE; El-Khuffash A; Jain A; McNamara PJ
    J Perinatol; 2016 Aug; 36(8):649-53. PubMed ID: 27054842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study protocol: baby-OSCAR trial: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies, a multicentre, masked, randomised placebo-controlled parallel group trial.
    Gupta S; Juszczak E; Hardy P; Subhedar N; Wyllie J; Kelsall W; Sinha S; Johnson S; Roberts T; Hutchison E; Pepperell J; Linsell L; Bell JL; Stanbury K; Laube M; Edwards C; Field D;
    BMC Pediatr; 2021 Feb; 21(1):100. PubMed ID: 33637074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patent Ductus Arteriosus of the Preterm Infant.
    Hamrick SEG; Sallmon H; Rose AT; Porras D; Shelton EL; Reese J; Hansmann G
    Pediatrics; 2020 Nov; 146(5):. PubMed ID: 33093140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Active versus restrictive ligation strategy for patent ductus arteriosus - A retrospective two-center study of extremely preterm infants born between 22 + 0 and 25 + 6 weeks of gestational age.
    Söderström F; Sindelar R; Olsson KW; Yousef S; Todorova D; Pestalozzi J; Mellander M; Raaijmakers R
    Early Hum Dev; 2024 Apr; 191():105976. PubMed ID: 38452632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal timing of video-assisted thoracoscopic surgery for patent ductus arteriosus in preterm infants born at ≤ 28 weeks of gestation.
    Kemmochi M; Senzaki H; Miyaji K; Hashimoto M; Yamaguchi A; Ooka M; Yokozeki Y; Ishii M
    Pediatr Int; 2019 Aug; 61(8):792-796. PubMed ID: 31199535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical markers may identify preterm infants with a patent ductus arteriosus at high risk of death or severe intraventricular haemorrhage.
    El-Khuffash A; Barry D; Walsh K; Davis PG; Molloy EJ
    Arch Dis Child Fetal Neonatal Ed; 2008 Nov; 93(6):F407-12. PubMed ID: 18285375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonsteroidal anti-inflammatory administration and patent ductus arteriosus ligation, a survey of practice preferences at US children's hospitals.
    Slaughter JL; Reagan PB; Bapat RV; Newman TB; Klebanoff MA
    Eur J Pediatr; 2016 Jun; 175(6):775-83. PubMed ID: 26879388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants.
    ElHassan NO; Bird TM; King AJ; Ambadwar PB; Jaquiss RD; Kaiser JR; Robbins JM
    J Neonatal Perinatal Med; 2014 Jan; 7(3):229-35. PubMed ID: 25322995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.